A Win For Galmed Pharmaceuticals Ltd.
Wed, Aug 21, 2024 at 07:42 PM
Galmed Pharmaceuticals Ltd. (GLMD:NASDAQ) shot up at $0.43, representing a gain of 42.4%. On Wed, Aug 21, 2024, GLMD:NASDAQ touched a New 2-Week High of $0.43. The stock appeared on our News Catalysts scanner on Mon, Aug 12, 2024 at 01:30 PM in the 'EARNINGS' category. From Wed, Aug 07, 2024, the stock recorded 50.00% Up Days and 18.18% Green Days
About Galmed Pharmaceuticals Ltd. (GLMD:NASDAQ)
Galmed Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company. It is engaged in the development and commercialization of oral therapy for the treatment of liver diseases and cholesterol gallstones.
Top 10 Gainers:
- Movella Holdings Inc Com (MVLA:NASDAQ), 170.27%
- GD Culture Group Ltd Com (New) (GDC:NASDAQ), 127.91%
- Stronghold Digital Mining Inc. (SDIG:NASDAQ), 82.25%
- Virax Biolabs Group Limited (VRAX:NASDAQ), 79.78%
- NextPlay Technologies Inc. (NXTP:NASDAQ), 76.92%
- F45 Training Holdings Inc. (FXLV:NYSE), 66.67%
- Smart for Life Inc. (SMFL:NASDAQ), 61.86%
- Neonode Inc. (NEON:NASDAQ), 51.49%
- B. Riley Financial, Inc. (RILY:NASDAQ), 45.67%
- Galmed Pharmaceuticals Ltd. (GLMD:NASDAQ), 42.43%